Teva Pharmaceutical Industries Ltd.

Regulatory Filings • Apr 17, 2024

����� ������� �-SEC ���� ���� ���� �- 10K ���� 2023 ������ ���� 12.2.2024 false

��� ������ ��������� ��"�	2 380
TEVA- PHARMACEUTICAL INDUSTRIES LTD
Corporation no: 520013954	10205
- - -

	Israel Securities Authority			Tel Aviv Stock Exchange		C002 ( Public )		Reported via MAGNA:	16/04/2024
	www.isa.gov.il			www.tase.co.il				Reference:	2024-02-043578	Time of broadcast: 23:20 23:20

---

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

	The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report on����� ������� �-SEC ���� ���� ���� �- 10K ���� 2023 ������ ���� 12.2.2024

2023_Form_10K_ARS_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
- - -
Stock Exchange/Market: NYSE	Date of revision of form structure: 20/02/2024
Address: Dvora Hanevi'a 124 , Tel Aviv 6944020   , Tel: 03-9148262 , Fax: 03-9267519
E-mail address: Yael.Ashman@teva.co.il
Previous names of reporting entity:
Name of the Signatory: Bergwerk Dov Position of Signatory in the reporting corporation: Vice President & General Counsel Name of Employer Company:
Address: Dvora Hanevi'a 124 , Tel Aviv 6944020 Telephone: 03-9267756 Facsimile: 03-9267429 E-mail: Shira.Aran-Porat@tevapharm.com 1